Wet AMDโs Problem Was Never the Drug. It Was the Injections. Athithi Verma July 27, 2026 Susvimo won a CHMP recommendation as Europe’s first continuous-delivery wet AMD treatment, replacing monthly eye injections with two implant refills a year. ADCs Graduated From Salvage to First Line, Twice in a Week Europe Backs the Cholesterol Class That Failed Four Times The Cheapest Drug in Retina Just Became a Branded Product China Stopped Excluding Patented Drugs From Its Price Cuts. Now the Bidder Signs for the Risk. OrphanPulse Wk 30: CHMP Backs a Drug It Refused Twice Editor’s Pick One Trial Miss Cut AstraZenecaโs Cushion Above $80bn to $800m White House and London Clinch Drug-Pricing Deal With 25% UK Price Lift Takeover Battle: Novo Nordisk Wins Brave Court Victory in $10B Metsera Deal Amid FTC ProbeNeuroPulse NeuroPulse Wk 30: Three Orexin Programmes in Two Weeks NeuroPulse Wk 29: First Brain Link Shares Movement Between Two PeopleOrphanPulse OrphanPulse Wk 30: CHMP Backs a Drug It Refused Twice OrphanPulse Wk 29: Ionis Takes SMA-Proven Antisense Into Dravet SyndromeDealPulse Signal DealPulse Signal Wk 30: Three Billion-Dollar Deals, No Drugs DealPulse Signal Wk 29: The Biggest Deal of the Week Was a Bare LineDealPulse Report DealFlow H1 2026: M&A Doubles as Upfront Spending Hits $174BThe Beats DealPulse Signal Wk 30: Three Billion-Dollar Deals, No Drugs DealPulse Signal Wk 29: The Biggest Deal of the Week Was a Bare Line DealFlow H1 2026: M&A Doubles as Upfront Spending Hits $174BAnalysis 7 Market Access Trends Reshaping Pharmaย by 2027 The Biologics Patent Cliff: Inside Pharma’s 2026-2029 ReckoningCoverage The ADC Decade Accelerates: What to Watch at ASCO 2026The Briefs Wet AMDโs Problem Was Never the Drug. It Was the Injections. Athithi Verma July 27, 2026 ADCs Graduated From Salvage to First Line, Twice in a Week Athithi Verma July 27, 2026 Europe Backs the Cholesterol Class That Failed Four Times Athithi Verma July 27, 2026 The Cheapest Drug in Retina Just Became a Branded Product Athithi Verma July 27, 2026 China Stopped Excluding Patented Drugs From Its Price Cuts. Now the Bidder Signs for the Risk. Athithi Verma July 27, 2026 Agilent Has Built an Annuity on Merckโs Clinical Programme, One Indication at a Time Athithi Verma July 23, 2026 Read More
Wet AMDโs Problem Was Never the Drug. It Was the Injections. Athithi Verma July 27, 2026 Susvimo won a CHMP recommendation as Europe’s first continuous-delivery wet AMD treatment, replacing monthly eye injections with two implant refills a year.
China Stopped Excluding Patented Drugs From Its Price Cuts. Now the Bidder Signs for the Risk. Athithi Verma July 27, 2026
Agilent Has Built an Annuity on Merckโs Clinical Programme, One Indication at a Time Athithi Verma July 23, 2026